QA: Immunome Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001472012_2023_Immunome_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001472012, Immunome Inc.

  xvar xval
0 AssetsCurrent 22,649,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 681,000
3 remainder_Assets 716,000
4 LiabilitiesCurrent 7,331,000
5 LiabilitiesNoncurrent 62,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,629,000
9 ResearchAndDevelopmentExpense 23,272,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 5,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 24,046,000
1 Liabilities 7,393,000
2 Expenses 36,901,000
3 Revenues 0
4 StockholdersEquity 16,653,000
5 NetIncome -36,896,000
6 ComprehensiveNetIncome -36,896,000
7 BaseVar 34,172,500
8 EconomicCapitalRatio -0.525

Edgar->Model Mapping

Feature Distribution

Change over Time